LOXL2 and hepatocellular carcinoma: Significant differences in the post-SVR incidence rate of HCC were observed when the patients were divided into two groups by either LOXL2 (< 2.08 vs. ≥ 2.08 ng/mL) or AFP (< 5.0 vs. ≥ 5.0 ng/mL) post-Tx levels (p = 0.013 and < 0.001, respectively).